Works by Singh-Kandah, Shahnaz


Results: 8
    1
    2
    3
    4

    Intermittent MEK inhibition for the treatment of metastatic uveal melanoma.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.975643
    By:
    • Khan, Shaheer;
    • Patel, Sapna P.;
    • Shoushtari, Alexander N.;
    • Ambrosini, Grazia;
    • Cremers, Serge;
    • Shing Lee;
    • Franks, Lauren;
    • Singh-Kandah, Shahnaz;
    • Hernandez, Susana;
    • Sender, Naomi;
    • Vuolo, Kristina;
    • Nesson, Alexandra;
    • Mundi, Prabhjot;
    • Izar, Benjamin;
    • Schwartz, Gary K.;
    • Carvajal, Richard D.
    Publication type:
    Article
    5

    Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.976837
    By:
    • Khan, Shaheer;
    • Lutzky, Jose;
    • Shoushtari, Alexander N.;
    • Jeter, Joanne;
    • Marr, Brian;
    • Olencki, Thomas E.;
    • Cebulla, Colleen M.;
    • Abdel-Rahman, Mohamed;
    • Harbour, J. William;
    • Sender, Naomi;
    • Nesson, Alexandra;
    • Singh-Kandah, Shahnaz;
    • Hernandez, Susana;
    • King, Jeanelle;
    • Katari, Manpreet S.;
    • Dimapanat, Lyssa;
    • Izard, Stephanie;
    • Ambrosini, Grazia;
    • Surriga, Oliver;
    • Rai, Alex J.
    Publication type:
    Article
    6
    7
    8